Artificial Intelligence-enhanced Electrocardiogram Diagnoses and Predicts Future Regurgitant Valvular Heart Diseases

NCT06475157 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500000

Last updated 2024-07-05

No results posted yet for this study

Summary

This is a retrospective study to establish models for the prediction of future valvular heart diseases with artificial intelligence-enhanced electrocardiogram (ECG).

Conditions

  • Electrocardiogram, Valvular Heart Disease

Interventions

OTHER

No intervention

No intervention is applied.

Sponsors & Collaborators

  • Shanghai Zhongshan Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2024-05-30
Completion
2024-05-30

Countries

  • China
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06475157 on ClinicalTrials.gov